FDA Inspection 877010 — Boehringer Ingelheim Pharma GmbH & Co. KG

Boehringer Ingelheim Pharma GmbH & Co. KG — FEI 3002806556

The FDA completed an inspection of Boehringer Ingelheim Pharma GmbH & Co. KG on March 7, 2014 in Ingelheim am Rhein. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 7, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ingelheim am Rhein (Germany)